Literature DB >> 33768926

Nicorandil-induced colovesical fistula in a patient with diverticular disease.

James D Noyes1, Ify R Mordi1, Qaiser Zeb1, Chim C Lang1.   

Abstract

Nicorandil's adverse effects can cause severe patient morbidity and can present to any specialty. Those with underlying diverticular disease are most susceptible. Medication reviews are vital for patients presenting with ulcer or fistula symptoms.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Year:  2021        PMID: 33768926      PMCID: PMC7981709          DOI: 10.1002/ccr3.3888

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


  13 in total

1.  The role of Nicorandil in non-healing surgical wounds.

Authors:  A D Riddell; U Minhas; G L Williams; K J Harding
Journal:  Ann R Coll Surg Engl       Date:  2010-06-21       Impact factor: 1.891

2.  The genetic influence on diverticular disease--a twin study.

Authors:  J Granlund; T Svensson; O Olén; F Hjern; N L Pedersen; P K E Magnusson; P Thelin Schmidt
Journal:  Aliment Pharmacol Ther       Date:  2012-03-20       Impact factor: 8.171

3.  Painful perianal ulcers with nicorandil.

Authors:  Patricia McGettigan; Robin E Ferner
Journal:  BMJ       Date:  2020-09-15

4.  Nicorandil and idiopathic anal ulceration.

Authors:  Mark Katory; Ben Davies; Clive Kelty; Ramesh Arasaradnam; Paul Skinner; Steve Brown; John Bagley; Andrew J Shorthouse; Lesley M Hunt; Richard Slater
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

5.  Nicorandil: from ulcer to fistula into adjacent organs.

Authors:  Philippe Trechot; Nadine Petitpain; Claire Guy; Astrid Pinzano; Lucie Javot; Jean Luc Schmutz; Béatrice Marie; Annick Barbaud
Journal:  Int Wound J       Date:  2012-03-28       Impact factor: 3.315

Review 6.  Diverticular disease: epidemiology and management.

Authors:  Adam V Weizman; Geoffrey Christopher Nguyen
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

7.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

Authors: 
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

Review 8.  Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance network.

Authors:  Valérie Babic; Nadine Petitpain; Claire Guy; Philippe Trechot; Anne Claire Bursztejn; Jean Luc Faillie; Thierry Vial; Jean Luc Schmutz; Pierre Gillet
Journal:  Int Wound J       Date:  2018-05-16       Impact factor: 3.315

9.  Genetic Risk of Diverticular Disease Predicts Early Stoppage of Nicorandil.

Authors:  James D Noyes; Ify R Mordi; Alexander S Doney; Colin N A Palmer; Ewan R Pearson; Chim C Lang
Journal:  Clin Pharmacol Ther       Date:  2020-07-10       Impact factor: 6.875

10.  Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms.

Authors:  Clemens Schafmayer; James William Harrison; Stephan Buch; Thilo Wedel; Christian Datz; Andrea Gsur; Michael N Weedon; Jochen Hampe; Christina Lange; Matthias C Reichert; Philipp Hofer; François Cossais; Juozas Kupcinskas; Witigo von Schönfels; Bodo Schniewind; Wolfgang Kruis; Jürgen Tepel; Myrko Zobel; Jonas Rosendahl; Thorsten Jacobi; Andreas Walther-Berends; Michael Schroeder; Ilka Vogel; Petr Sergeev; Hans Boedeker; Holger Hinrichsen; Andreas Volk; Jens-Uwe Erk; Greta Burmeister; Alexander Hendricks; Sebastian Hinz; Sebastian Wolff; Martina Böttner; Andrew R Wood; Jessica Tyrrell; Robin N Beaumont; Melanie Langheinrich; Torsten Kucharzik; Stefanie Brezina; Ursula Huber-Schönauer; Leonora Pietsch; Laura Sophie Noack; Mario Brosch; Alexander Herrmann; Raghavan Veera Thangapandi; Hans Wolfgang Schimming; Sebastian Zeissig; Stefan Palm; Gerd Focke; Anna Andreasson; Peter T Schmidt; Juergen Weitz; Michael Krawczak; Henry Völzke; Gernot Leeb; Patrick Michl; Wolfgang Lieb; Robert Grützmann; Andre Franke; Frank Lammert; Thomas Becker; Limas Kupcinskas; Mauro D'Amato
Journal:  Gut       Date:  2019-01-19       Impact factor: 23.059

View more
  2 in total

1.  Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database.

Authors:  Kaito Yamashiro; Mika Jouta; Kouichi Hosomi; Satoshi Yokoyama; Yuu Ozaki; Atsushi Hirata; Fumihiko Ogata; Takehiro Nakamura; Shigeharu Tanei; Naohito Kawasaki
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 2.  Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs.

Authors:  James D Noyes; Ify R Mordi; Alexander S Doney; Rahman Jamal; Chim C Lang
Journal:  Diseases       Date:  2021-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.